The MOTS-c price that matters is the one on a single 10 mg vial: $75.00 listed, $37.50 with the code PEPTIDEDECK, which works out at $3.75 per milligram. There is one SKU, so quantity is the only other lever.
Key takeaways
- One product exists: MOTS-C, 10 mg, lyophilized. It lists at $75.00, reduced from $89.99, and falls to $37.50 with the code PEPTIDEDECK. That is $3.75 per milligram.
- There is no second vial size to compare against, so the usual per-mg argument between a small and a large vial does not apply here. Quantity is the only other axis.
- Quantity tiers take 3%, 5% and 10% off the list price at three, five and ten vials. The code is worth far more than any tier, and whether the two combine is a cart question rather than a published policy.
- Insurance is irrelevant, not expensive. There is no approved MOTS-c product in any market, so there is nothing for a plan to cover and no billing code to submit.
- Free shipping starts at $250. A single discounted vial at $37.50 is roughly seven vials short of that line.
The vendor we point lifters to
MOTS-c from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
Buying 3, 5 or 10 vials takes 3%, 5% or 10% off the list price. Free shipping starts at $250, which one discounted vial does not reach.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 19, 2026.
What the MOTS-c price looks like across the whole catalog
Searches for MOTS-c cost and price resolve to the same short answer, because there is only one product to price. Ascension lists a single MOTS-c product, a 10 mg lyophilized vial, currently $75.00 against a former price of $89.99. Because there is no 5 mg or 30 mg version, the per milligram figure never moves with strength. It moves with order size and with the code.
| Order | Price per vial | Order total | Cost per mg |
|---|---|---|---|
| 1 vial, list price | $75.00 | $75.00 | $7.50 |
| 1 vial with PEPTIDEDECK | $37.50 | $37.50 | $3.75 |
| 3 vials, 3% tier | $72.75 | $218.25 | $7.28 |
| 5 vials, 5% tier | $71.25 | $356.25 | $7.13 |
| 10 vials, 10% tier | $67.50 | $675.00 | $6.75 |
Read the second row against the last one. Ten vials at the deepest published tier still cost $67.50 each. One vial with the code costs $37.50. The tiers are a rounding error next to a half-price code, which is unusual and worth saying plainly, because in most catalogs the volume discount is the serious lever and the code is decoration.
Whether a code and a tier apply to the same order is not documented anywhere we can point to, so do not budget as if they stack. Build the cart, apply the code, and read the total that appears. That number is the only authority.
MOTS-c cost without insurance is the only cost there is
The phrasing comes from the drug market next door. People pricing semaglutide or tirzepatide really do face two numbers, a covered price and a cash price, and the gap between them is the whole story. There is no equivalent gap here.
Insurance pays for products that hold a marketing authorization, carry a billing code, and can be prescribed. MOTS-c holds none of those. It has never been approved by the FDA, the EMA or the MHRA, no pharmacy can lawfully dispense it, and nothing sold under the name is a medicine. Asking what MOTS-c costs without insurance is asking what it costs, full stop.
The same logic closes the HSA and FSA question. Those accounts reimburse qualified medical expenses, and material sold and bought as laboratory research supply is not one. If your reference point is the coverage fight around incretins, the GLP-1 medications guide sets out how that market actually prices, and it has nothing in common with this one.
The $250 shipping line and how far one vial sits from it
Free delivery starts above $250. That threshold was written against list prices, and a half-price code pushes a small order well under it.
The arithmetic is quick. At $37.50 a vial, six discounted vials come to $225.00 and seven come to $262.50, so roughly seven vials clear the line. At list price, four vials clear it. A first order of one vial is nowhere near, and it will carry a shipping charge.
That is the right first order anyway. One vial is the cheapest way to find out whether the lot number printed on the vial matches the certificate you were shown, whether the cake inside arrived intact rather than as a smear on the wall of the glass, and whether the invoice describes research material. Buying seven vials to save a shipping fee commits seven times the money to a supplier you have not tested. The checklist for that first test is set out in the sibling article on where to buy MOTS-c.
What $3.75 per milligram buys against other research peptides
The MOTS-c price only becomes meaningful next to the rest of the market. Cost per milligram here tracks synthesis difficulty and production scale, not biological interest. MOTS-c is a 16 amino acid chain, short enough for routine solid-phase synthesis, and it sells in 10 mg units. That is why the number lands where it does.
Two comparisons from elsewhere on this site put it in context. Retatrutide at the same supplier runs $4.17 to $4.95 per milligram depending on vial size, as broken down in retatrutide price. Follistatin sits in a completely different band, roughly $130 to $170 per milligram, because it is a much larger protein sold in 1 mg vials, which the follistatin vendor comparison covers in detail.
So $3.75/mg is unremarkable for a short peptide, which is the useful conclusion. A listing far below its class band is usually saying something about the label rather than about the seller's generosity, and every concentration figure a researcher works with is derived from the milligram number on that label.
What the MOTS-c cost does not include
It does not include a human evidence base, and that matters more here than the money does.
MOTS-c is encoded inside mitochondrial DNA and was characterized by Lee and colleagues in Cell Metabolism in 2015 as a regulator of metabolic homeostasis acting through AMPK. That work was done in cells and in mice: improved insulin sensitivity, resistance to diet-induced obesity, altered glucose handling in rodents. It is genuinely interesting biology and it is not a human result.
The closest thing to a human program was CB4211, an analogue rather than MOTS-c itself, which CohBar carried through a Phase 1a/1b study in healthy volunteers and in subjects with non-alcoholic fatty liver disease. That study completed and the company subsequently wound down. There is no Phase 3, no large efficacy trial, and no human performance data at all.
Vendor documentation is the other thing the price does not guarantee on its own. Ascension publishes two third-party certificates per batch, from Kovera Labs and MZ Biolabs, and those published certificates are the reason this supplier is the one recommended here. Read the certificate for the batch currently shipping rather than an archived one, then check the lot number against the vial when it arrives.
Costing one vial against the rest of a training block
On a site about lean mass, $37.50 is not the expensive part of anything. It is less than a month of creatine and whey for most lifters and a fraction of the grocery bill that separates a controlled bulk from a sloppy one.
That is exactly why the price should not drive the decision. MOTS-c gets marketed as an exercise mimetic because AMPK activation overlaps with a signal that training already produces. Mitochondrial density, capillary supply and substrate handling respond to endurance and resistance work with a reliability that no research peptide currently has evidence to match, and programming costs nothing at the checkout.
So the framing splits cleanly. Bought as an addition to hard training by someone who reads certificates, $37.50 is noise in the budget and documentation is the only interesting variable. Bought as a substitute for hard training, no price is low enough, because the substitution is not supported by anything in the literature. That test survives the move to any other cheap research vial, and we run it on a compound sold against focus rather than endurance in Semax price.
Insulin sensitivity is where the two agendas meet, since it is the outcome most consistently reported in the rodent work and it also swings across a bulk and a cut for reasons that have nothing to do with peptides. The muscle side of that relationship is covered in myostatin, insulin resistance and type 2 diabetes, and the training side in resistance training and myostatin.
Frequently asked questions
How much does MOTS-c cost per vial?
The 10 mg vial lists at $75.00 and falls to $37.50 with the code PEPTIDEDECK, which is $3.75 per milligram. Those figures were checked on August 19, 2026, and the checkout total is always the authority over any number published elsewhere.
Is there a cheaper vial size?
No. Unlike retatrutide, which is sold in two strengths, MOTS-c has a single 10 mg SKU. There is no smaller trial size and no bulk vial, so the MOTS-c price per milligram is fixed by the code and the quantity tier rather than by strength.
Does ordering ten vials beat using the code?
Not on the published numbers. The ten-vial tier takes 10% off list, giving $67.50 a vial, while the code takes 50%, giving $37.50. Whether both can apply to one order is undocumented, so verify it in the cart rather than assuming it.
Can insurance, an HSA or an FSA pay for MOTS-c?
No. Coverage and tax-advantaged reimbursement both require an approved medical product and a qualified medical expense. MOTS-c has no marketing authorization anywhere and is sold as laboratory research material, which places it outside both systems entirely.
Why is MOTS-c so much cheaper per milligram than follistatin?
Size and scale. MOTS-c is a 16 amino acid peptide sold in 10 mg vials, while follistatin is a large protein typically sold in 1 mg vials. Synthesis cost scales with chain length and complexity, which is most of the gap between $3.75/mg and $130/mg or more.
This article is for educational purposes only and is not medical advice. MOTS-c is not an approved medicine in any market, has no prescription route, and material sold by research suppliers is labeled for laboratory use only and not for human consumption. Speak with a qualified healthcare professional before making any decision involving peptides, injections, or unapproved compounds.